The National Center for Immunization and Respiratory Diseases (NCIRD) is offering a grant to collaborate with the Chinese Center for Disease Control and Prevention (China CDC) in Beijing. This grant aims to enhance influenza surveillance, research, and prevention strategies in China and globally. Research will focus on understanding influenza impacts, evaluating antiviral medications, vaccines, and prevention methods, and guiding epidemic and pandemic control efforts. The goal is to prevent the spread of novel influenza viruses internationally and inform global health policies. Applications for this grant must be submitted by March 21, 2018.
Opportunity ID: 298954
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-18-004 |
| Funding Opportunity Title: | Public Health Epidemiology of Influenza Virus Infection and Control in China |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.083 — Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 8 |
| Posted Date: | Nov 22, 2017 |
| Last Updated Date: | Feb 02, 2018 |
| Original Closing Date for Applications: | Jan 22, 2018 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | Mar 21, 2018 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Apr 20, 2018 |
| Estimated Total Program Funding: | $10,000,000 |
| Award Ceiling: | $2,000,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Eligibility of this cooperative agreement is limited to the Chinese Center for Disease Control and Prevention, Beijing, China. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The National Center for Immunization and Respiratory Diseases (NCIRD), Influenza Division (ID), seeks to initiate a cooperative agreement with the Chinese Center for Disease Control and Prevention (China CDC), Beijing, China. The purpose of this collaboration is to support enhanced influenza surveillance and applied research to better define the global risk of novel and seasonal influenza virus infections in humans and animals in China, the region and the world. The scope of research performed will include, but will not be limited to, activities that: a) determine the impact of influenza among vulnerable populations; b) assess the value of antiviral medications, vaccines and other mitigation strategies, and c) support and guide seasonal epidemic and pandemic influenza prevention and control studies. Research activities for the prevention and control of novel influenza viruses and pandemic preparedness activities will be aimed at preventing and controlling the spread and transmission of novel influenza viruses to other countries, including the United States. Continued monitoring, detection, and reporting of these novel influenza viruses in China will advance efforts to inform global health infection control policies and prevent and control seasonal epidemic and pandemic influenza in countries around the world. |
| Link to Additional Information: | |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Deborah Loveys
hft6@cdc.gov Email:hft6@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| February 2, 2018
ACTION ITEM: The application package for this NOFO has been revised to comply with form compatibility at Grants.gov and eRA Commons. All applicants are required to go to Grants.gov and retrieve the revised application package in order for it to pass, Grants.gov and eRA Commons validation. If you have any questions please contact OGSTIMS for assistance. |
Feb 02, 2018 | |
| February 2, 2018
ACTION ITEM: The application package for this NOFO has been revised to comply with form compatibility at Grants.gov and eRA Commons. All applicants are required to go to Grants.gov and retrieve the revised application package in order for it to pass, Grants.gov and eRA Commons validation. If you have any questions please contact OGSTIMS for assistance. |
Feb 02, 2018 | |
| February 2, 2018
ACTION ITEM: The application package for this NOFO has been revised to comply with form compatibility at Grants.gov and eRA Commons. All applicants are required to go to Grants.gov and retrieve the revised application package in order for it to pass, Grants.gov and eRA Commons validation. If you have any questions please contact OGSTIMS for assistance. |
Feb 02, 2018 | |
| Updated the application package with additional forms | Feb 02, 2018 | |
| Updated Application Package for RFA-IP-18-004 to the new (FORMS-E CDC U01 Research New). | Nov 30, 2017 | |
| revised closing date to March 21, 2018 | Nov 27, 2017 | |
| REVISED CLOSING DATE MARCH 21, 2018 | Nov 22, 2017 | |
| Nov 22, 2017 |
DISPLAYING: Synopsis 8
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-18-004 |
| Funding Opportunity Title: | Public Health Epidemiology of Influenza Virus Infection and Control in China |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.083 — Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 8 |
| Posted Date: | Nov 22, 2017 |
| Last Updated Date: | Feb 02, 2018 |
| Original Closing Date for Applications: | Jan 22, 2018 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | Mar 21, 2018 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Apr 20, 2018 |
| Estimated Total Program Funding: | $10,000,000 |
| Award Ceiling: | $2,000,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Eligibility of this cooperative agreement is limited to the Chinese Center for Disease Control and Prevention, Beijing, China. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The National Center for Immunization and Respiratory Diseases (NCIRD), Influenza Division (ID), seeks to initiate a cooperative agreement with the Chinese Center for Disease Control and Prevention (China CDC), Beijing, China. The purpose of this collaboration is to support enhanced influenza surveillance and applied research to better define the global risk of novel and seasonal influenza virus infections in humans and animals in China, the region and the world. The scope of research performed will include, but will not be limited to, activities that: a) determine the impact of influenza among vulnerable populations; b) assess the value of antiviral medications, vaccines and other mitigation strategies, and c) support and guide seasonal epidemic and pandemic influenza prevention and control studies. Research activities for the prevention and control of novel influenza viruses and pandemic preparedness activities will be aimed at preventing and controlling the spread and transmission of novel influenza viruses to other countries, including the United States. Continued monitoring, detection, and reporting of these novel influenza viruses in China will advance efforts to inform global health infection control policies and prevent and control seasonal epidemic and pandemic influenza in countries around the world. |
| Link to Additional Information: | |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Deborah Loveys
hft6@cdc.gov Email:hft6@cdc.gov |
DISPLAYING: Synopsis 7
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-18-004 |
| Funding Opportunity Title: | Public Health Epidemiology of Influenza Virus Infection and Control in China |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.083 — Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 7 |
| Posted Date: | Feb 02, 2018 |
| Last Updated Date: | Feb 02, 2018 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Mar 21, 2018 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Apr 20, 2018 |
| Estimated Total Program Funding: | $10,000,000 |
| Award Ceiling: | $2,000,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Eligibility of this cooperative agreement is limited to the Chinese Center for Disease Control and Prevention, Beijing, China. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The National Center for Immunization and Respiratory Diseases (NCIRD), Influenza Division (ID), seeks to initiate a cooperative agreement with the Chinese Center for Disease Control and Prevention (China CDC), Beijing, China. The purpose of this collaboration is to support enhanced influenza surveillance and applied research to better define the global risk of novel and seasonal influenza virus infections in humans and animals in China, the region and the world. The scope of research performed will include, but will not be limited to, activities that: a) determine the impact of influenza among vulnerable populations; b) assess the value of antiviral medications, vaccines and other mitigation strategies, and c) support and guide seasonal epidemic and pandemic influenza prevention and control studies. Research activities for the prevention and control of novel influenza viruses and pandemic preparedness activities will be aimed at preventing and controlling the spread and transmission of novel influenza viruses to other countries, including the United States. Continued monitoring, detection, and reporting of these novel influenza viruses in China will advance efforts to inform global health infection control policies and prevent and control seasonal epidemic and pandemic influenza in countries around the world. |
| Link to Additional Information: | |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Deborah Loveys
hft6@cdc.gov Email:hft6@cdc.gov |
DISPLAYING: Synopsis 6
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-18-004 |
| Funding Opportunity Title: | Public Health Epidemiology of Influenza Virus Infection and Control in China |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.083 — Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 6 |
| Posted Date: | Feb 02, 2018 |
| Last Updated Date: | Feb 02, 2018 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Mar 21, 2018 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Apr 20, 2018 |
| Estimated Total Program Funding: | $10,000,000 |
| Award Ceiling: | $2,000,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Eligibility of this cooperative agreement is limited to the Chinese Center for Disease Control and Prevention, Beijing, China. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The National Center for Immunization and Respiratory Diseases (NCIRD), Influenza Division (ID), seeks to initiate a cooperative agreement with the Chinese Center for Disease Control and Prevention (China CDC), Beijing, China. The purpose of this collaboration is to support enhanced influenza surveillance and applied research to better define the global risk of novel and seasonal influenza virus infections in humans and animals in China, the region and the world. The scope of research performed will include, but will not be limited to, activities that: a) determine the impact of influenza among vulnerable populations; b) assess the value of antiviral medications, vaccines and other mitigation strategies, and c) support and guide seasonal epidemic and pandemic influenza prevention and control studies. Research activities for the prevention and control of novel influenza viruses and pandemic preparedness activities will be aimed at preventing and controlling the spread and transmission of novel influenza viruses to other countries, including the United States. Continued monitoring, detection, and reporting of these novel influenza viruses in China will advance efforts to inform global health infection control policies and prevent and control seasonal epidemic and pandemic influenza in countries around the world. |
| Link to Additional Information: | |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Deborah Loveys
hft6@cdc.gov Email:hft6@cdc.gov |
DISPLAYING: Synopsis 5
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-18-004 |
| Funding Opportunity Title: | Public Health Epidemiology of Influenza Virus Infection and Control in China |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.083 — Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 5 |
| Posted Date: | Feb 02, 2018 |
| Last Updated Date: | Nov 30, 2017 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Mar 21, 2018 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Apr 20, 2018 |
| Estimated Total Program Funding: | $10,000,000 |
| Award Ceiling: | $2,000,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Eligibility of this cooperative agreement is limited to the Chinese Center for Disease Control and Prevention, Beijing, China. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The National Center for Immunization and Respiratory Diseases (NCIRD), Influenza Division (ID), seeks to initiate a cooperative agreement with the Chinese Center for Disease Control and Prevention (China CDC), Beijing, China. The purpose of this collaboration is to support enhanced influenza surveillance and applied research to better define the global risk of novel and seasonal influenza virus infections in humans and animals in China, the region and the world. The scope of research performed will include, but will not be limited to, activities that: a) determine the impact of influenza among vulnerable populations; b) assess the value of antiviral medications, vaccines and other mitigation strategies, and c) support and guide seasonal epidemic and pandemic influenza prevention and control studies. Research activities for the prevention and control of novel influenza viruses and pandemic preparedness activities will be aimed at preventing and controlling the spread and transmission of novel influenza viruses to other countries, including the United States. Continued monitoring, detection, and reporting of these novel influenza viruses in China will advance efforts to inform global health infection control policies and prevent and control seasonal epidemic and pandemic influenza in countries around the world. |
| Link to Additional Information: | |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Deborah Loveys
hft6@cdc.gov Email:hft6@cdc.gov |
DISPLAYING: Synopsis 4
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-18-004 |
| Funding Opportunity Title: | Public Health Epidemiology of Influenza Virus Infection and Control in China |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.083 — Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 4 |
| Posted Date: | Nov 30, 2017 |
| Last Updated Date: | Nov 27, 2017 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Mar 21, 2018 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Apr 20, 2018 |
| Estimated Total Program Funding: | $10,000,000 |
| Award Ceiling: | $2,000,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Eligibility of this cooperative agreement is limited to the Chinese Center for Disease Control and Prevention, Beijing, China. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The National Center for Immunization and Respiratory Diseases (NCIRD), Influenza Division (ID), seeks to initiate a cooperative agreement with the Chinese Center for Disease Control and Prevention (China CDC), Beijing, China. The purpose of this collaboration is to support enhanced influenza surveillance and applied research to better define the global risk of novel and seasonal influenza virus infections in humans and animals in China, the region and the world. The scope of research performed will include, but will not be limited to, activities that: a) determine the impact of influenza among vulnerable populations; b) assess the value of antiviral medications, vaccines and other mitigation strategies, and c) support and guide seasonal epidemic and pandemic influenza prevention and control studies. Research activities for the prevention and control of novel influenza viruses and pandemic preparedness activities will be aimed at preventing and controlling the spread and transmission of novel influenza viruses to other countries, including the United States. Continued monitoring, detection, and reporting of these novel influenza viruses in China will advance efforts to inform global health infection control policies and prevent and control seasonal epidemic and pandemic influenza in countries around the world. |
| Link to Additional Information: | |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Deborah Loveys
hft6@cdc.gov Email:hft6@cdc.gov |
DISPLAYING: Synopsis 3
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-18-004 |
| Funding Opportunity Title: | Public Health Epidemiology of Influenza Virus Infection and Control in China |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.083 — Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 3 |
| Posted Date: | Nov 27, 2017 |
| Last Updated Date: | Nov 22, 2017 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Mar 21, 2018 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Apr 20, 2018 |
| Estimated Total Program Funding: | $10,000,000 |
| Award Ceiling: | $2,000,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Eligibility of this cooperative agreement is limited to the Chinese Center for Disease Control and Prevention, Beijing, China. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The National Center for Immunization and Respiratory Diseases (NCIRD), Influenza Division (ID), seeks to initiate a cooperative agreement with the Chinese Center for Disease Control and Prevention (China CDC), Beijing, China. The purpose of this collaboration is to support enhanced influenza surveillance and applied research to better define the global risk of novel and seasonal influenza virus infections in humans and animals in China, the region and the world. The scope of research performed will include, but will not be limited to, activities that: a) determine the impact of influenza among vulnerable populations; b) assess the value of antiviral medications, vaccines and other mitigation strategies, and c) support and guide seasonal epidemic and pandemic influenza prevention and control studies. Research activities for the prevention and control of novel influenza viruses and pandemic preparedness activities will be aimed at preventing and controlling the spread and transmission of novel influenza viruses to other countries, including the United States. Continued monitoring, detection, and reporting of these novel influenza viruses in China will advance efforts to inform global health infection control policies and prevent and control seasonal epidemic and pandemic influenza in countries around the world. |
| Link to Additional Information: | |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Deborah Loveys
hft6@cdc.gov Email:hft6@cdc.gov |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-18-004 |
| Funding Opportunity Title: | Public Health Epidemiology of Influenza Virus Infection and Control in China |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.083 — Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Nov 22, 2017 |
| Last Updated Date: | Nov 22, 2017 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Mar 21, 2018 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Apr 20, 2018 |
| Estimated Total Program Funding: | $10,000,000 |
| Award Ceiling: | $2,000,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Eligibility of this cooperative agreement is limited to the Chinese Center for Disease Control and Prevention, Beijing, China. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The National Center for Immunization and Respiratory Diseases (NCIRD), Influenza Division (ID), seeks to initiate a cooperative agreement with the Chinese Center for Disease Control and Prevention (China CDC), Beijing, China. The purpose of this collaboration is to support enhanced influenza surveillance and applied research to better define the global risk of novel and seasonal influenza virus infections in humans and animals in China, the region and the world. The scope of research performed will include, but will not be limited to, activities that: a) determine the impact of influenza among vulnerable populations; b) assess the value of antiviral medications, vaccines and other mitigation strategies, and c) support and guide seasonal epidemic and pandemic influenza prevention and control studies. Research activities for the prevention and control of novel influenza viruses and pandemic preparedness activities will be aimed at preventing and controlling the spread and transmission of novel influenza viruses to other countries, including the United States. Continued monitoring, detection, and reporting of these novel influenza viruses in China will advance efforts to inform global health infection control policies and prevent and control seasonal epidemic and pandemic influenza in countries around the world. |
| Link to Additional Information: | |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Deborah Loveys
hft6@cdc.gov Email:hft6@cdc.gov |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-18-004 |
| Funding Opportunity Title: | Public Health Epidemiology of Influenza Virus Infection and Control in China |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.083 — Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 22, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jan 22, 2018 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Feb 21, 2018 |
| Estimated Total Program Funding: | $10,000,000 |
| Award Ceiling: | $2,000,000 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Eligibility of this cooperative agreement is limited to the Chinese Center for Disease Control and Prevention, Beijing, China. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The National Center for Immunization and Respiratory Diseases (NCIRD), Influenza Division (ID), seeks to initiate a cooperative agreement with the Chinese Center for Disease Control and Prevention (China CDC), Beijing, China. The purpose of this collaboration is to support enhanced influenza surveillance and applied research to better define the global risk of novel and seasonal influenza virus infections in humans and animals in China, the region and the world. The scope of research performed will include, but will not be limited to, activities that: a) determine the impact of influenza among vulnerable populations; b) assess the value of antiviral medications, vaccines and other mitigation strategies, and c) support and guide seasonal epidemic and pandemic influenza prevention and control studies. Research activities for the prevention and control of novel influenza viruses and pandemic preparedness activities will be aimed at preventing and controlling the spread and transmission of novel influenza viruses to other countries, including the United States. Continued monitoring, detection, and reporting of these novel influenza viruses in China will advance efforts to inform global health infection control policies and prevent and control seasonal epidemic and pandemic influenza in countries around the world. |
| Link to Additional Information: | |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Deborah Loveys
hft6@cdc.gov Email:hft6@cdc.gov |
Related Documents
Folder 298954 Full Announcement-RFA-IP-18-004 -> NOFO IP18 004 REVISED.pdf
Packages
| Agency Contact Information: | Deborah Loveys hft6@cdc.gov Email: hft6@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.083 | RFA-IP-18-004 | Public Health Epidemiology of Influenza Virus Infection and Control in China | PKG00236510 | Nov 22, 2017 | Mar 21, 2018 | View |
Package 1
Mandatory forms
298954 RR_SF424_2_0-2.0.pdf
298954 RR_Budget_1_4-1.4.pdf
298954 PHS398_ResearchPlan_4_0-4.0.pdf
298954 PHS398_CoverPageSupplement_4_0-4.0.pdf
298954 RR_OtherProjectInfo_1_4-1.4.pdf
298954 PerformanceSite_2_0-2.0.pdf
298954 RR_KeyPersonExpanded_2_0-2.0.pdf
Optional forms
298954 RR_SubawardBudget30_1_4-1.4.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
